Antiretroviral drugs
Executive Summary
Antiviral Drugs Advisory Committee will discuss pharmacokinetics of approved antiretroviral drugs for HIV at July 25 meeting. The committee will also consider the relationship of pharmacokinetic parameters and drug toxicity, safety and pediatric considerations for alternate dosing regimens. The meeting will be at the Holiday Inn in Gaithersburg, Md. at 8:30 a.m